Arena Group Holdings Faces Delisting Concerns

TL;DR

ARENA stock suspended from NYSE American, facing delisting. Big trouble.

AI Summary

Arena Group Holdings, Inc. filed an 8-K on October 8, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company's stock was previously suspended from trading on the NYSE American on October 2, 2024, due to its inability to meet certain continued listing standards. This filing indicates the company is addressing its listing status.

Why It Matters

This filing signals potential delisting from a major stock exchange, which could significantly impact the liquidity and valuation of Arena Group Holdings' stock.

Risk Assessment

Risk Level: high — The company has received a notice of delisting or failure to satisfy continued listing rules, indicating a severe risk to its stock market presence.

Key Players & Entities

• Arena Group Holdings, Inc. (company) — Registrant
• NYSE American (company) — Stock Exchange
• October 2, 2024 (date) — Date of stock suspension
• October 8, 2024 (date) — Filing date of the 8-K

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share AREN NYSE American Chec
• $2.0 million — ) requiring stockholders' equity of (i) $2.0 million or more if the Company has reported los
• $4.0 million — ts three most recent fiscal years, (ii) $4.0 million or more if the Company has reported los
• $6.0 million — four most recent fiscal years and (iii) $6.0 million or more if the Company has reported los

Filing Documents

• form8-k.htm (8-K) — 41KB
• ex99-1.htm (EX-99.1) — 13KB
• 0001493152-24-040442.txt ( ) — 231KB
• aren-20241002.xsd (EX-101.SCH) — 3KB
• aren-20241002_lab.xml (EX-101.LAB) — 33KB
• aren-20241002_pre.xml (EX-101.PRE) — 24KB
• form8-k_htm.xml (XML) — 4KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (Date of Earliest Event Reported): October 2, 2024 THE ARENA GROUP HOLDINGS, INC. (Exact name of registrant as specified in its charter) delaware 001-12471 68-0232575 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 200 VESEY STREET , 24TH FLOOR NEW YORK , new york 10281 (Address of principal executive offices) (Zip code) 212 - 321-5002 (Registrant's telephone number including area code) (Former name or former address if changed since last report) Securities registered pursuant in Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share AREN NYSE American Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 2, 2024, The Arena Group Holdings, Inc. (the "Company") received a notification ("Letter") from the NYSE American LLC (the "NYSE American") stating that the Company is not in compliance with the minimum stockholders' equity requirements of Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the "Company Guide") requiring stockholders' equity of (i) $2.0 million or more if the Company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, (ii) $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and (iii) $6.0 million or more if the Company has reported losses from continuing operations and/or net losses in its five most recent fiscal years, respectively. As of June 30, 2024, the Company had stockholders' deficit of $(157.2) million and has had losses in the most recent five fiscal years ended December 31, 2023. The Company is now subject to the procedures and requirements of Section 1009 of the Company Guide. The Company has until November 1, 2024, to submit a plan (the "Plan") of actions it has taken or will take to regain compliance with the continued listing standards by April 2, 2026, which is 18-months from receipt of the Letter ("Cure Period"). The Company intends to submit a plan to regain compliance with NYSE American listing standards. If the NYSE American accepts the Plan, the Company will be able to continue its listing during the Plan period and will be subject to periodic reviews including quarterly monitoring for compliance with the Plan until it has regained compliance. If the Plan is not accepted by the NYSE American, the Letter states that delisting proceedings will commence. The Company may appeal a staff delisting determination in accordance with Section 1010 and Part 12 of the Company Guide. The Company intends to regain compliance and the Letter has no immediate effect on the listing or trading of the Company's common stock on the NYSE American and if the Plan is approved and adhered to, during the Cure Period. The Company's receipt of the Letter from the NYSE American does not affect the Company's business, operations or reporting requirements with the U.S. Securities and Exchange Commission. Item 8.01 Other Events. On October 8, 2024, the Company issued a press release announcing its receipt of the Letter. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein. Item 9.01. Financial 99.1 Press release dated October 8, 2024 announcing NYSE American notification. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant

View Full Filing

View this 8-K filing on SEC EDGAR